Silicon Valley BioTalks

 

Silicon Valley BioTalks is the premier event for pharmaceutical and medical device professionals to build their knowledge and expertise. Since its launch, the Silicon Valley BioTalks has gathered over 600 clinical trials professionals from the Bay Area and beyond. The panel has featured over 30 clinical trials industry experts from leading life science companies including Roche, Abbott, Santen Pharmaceutical, Elan Pharmaceuticals and Johnson & Johnson.

 


 Join the BioTalks group on Linkedin to receive updates on the next session of this event. 

Take a tour of the previous sessions!

Silicon Valley BioTalks: How CDISC standards streamline clinical trials  

The Next Generation of Clinical Trial Analytics

June 26th, 2014 - Read the abstract

On June 26th 2014, Clinovo hosted the 9th Silicon Valley Biotalks at HP's headquarters in Palo Alto. The panel was composed of Suresh Madhavan (CEO at PointCross),  Sam Kalbag (CTO at Autonomy, an HP Company), Barbara Elashoff (CEO at Patient Profiles), and Kesha Rodgers (Associate Director of Clinical Systems at BioMarin). The discussion was moderated by Glenn Keet (CEO at Clinovo).

Silicon Valley BioTalks: How CDISC standards streamline clinical trials  

Manage In-House & Outsourced Clinical Trials: Vendor Selection, Project Coordination, and Resource Management.

March 19th, 2014 - Listen to the best moments

The eighth session of the Silicon Valley BioTalks hosted a panel of Outsourcing experts from leading pharmaceutical companies. The panel was composed of Alec Vardy (Senior Director, CDM & Clinical Programming at Onyx Pharmaceuticals), Michelle Gray (Instructor in Clinical Design at San Francisco State University) and Todd Reul (Associate Director, Clinical Outsourcing & Analytics at BioMarin Pharmaceutical). The discussion was moderated by Kenneth Milstead (Senior Project Manager at Clinovo).

Silicon Valley BioTalks - Is EDC becoming a commodity?  

CDISC for Medical Device Companies: Progress Made and Best Practices from Pharma/Biotech Implementation

October 10th, 2013 - Listen to the best moments

Now in its seventh session, this Silicon Valley BioTalks hosted a panel of CDISC experts from leading pharmaceutical and medical device companies. The panel was composed of CDISC thought-leaders: Carey Smoak (Roche Molecular Diagnostics, Senior Manager of SAS Programming, CDISC Device Team Leader), Dan Diprimeo (BioMarin Pharmaceutical, Director of Statistical Programming) and Peng Yang (Santen Pharmaceutical, Associate Director, Head of Statistical Programming). The panel will be moderated by Ale Gicqueau (Clinovo, President & CEO).

Silicon Valley BioTalks - Is EDC becoming a commodity?  

Is EDC becoming a commodity?

April 17th, 2013 - Listen to the best moments

On April 17th 2013, Clinovo hosted the Silicon Valley Biotalks at Onyx Pharmaceuticals in South San Francisco. The panel was composed of: Eric Morrie (Manager, Clinical Programming at Onyx Pharmaceuticals), Dr. Omar Dawood (M.D., M.P.H., Visionary Senior Executive, and Clinical Leader) and Marc Desgrousilliers (Chief Technology Officer? at Clinovo). The discussion was moderated by Dr. Bob Molinari (Ph.D., CEO of Retrotope Inc. & Partner of MedStars).

Silicon Valley BioTalks: How CDISC standards streamline clinical trials  

Winning Strategies for Clinical Data Integration

November 8th, 2012 - Read the abstracts

On November 8th 2012, Clinovo hosted the fifth Silicon Valley Biotalks, hosted by SNR Denton in their Palo Alto offices. The panel was composed of Clinical Data Management experts: Joe Warlow (Janssen Alzheimer Immunotherapy, Director of Clinical Data Management), Lauren Intagliata (Genomic Health, Associate Director of Clinical Data Management) and Chito Hernandez (Elan Pharmaceuticals, Vice President of Biometrics and Information Management).  The panel was moderated by Wessam Sonbol (Clinovo, Senior Data Management Study Lead | Founder of VOXCE).

Silicon Valley BioTalks - Is EDC becoming a commodity?  

FDA Submission: The New Rules

June 6th, 2012 - Read the extracts

On June 6th 2012, Clinovo hosted the fourth Silicon Valley Biotalks, hosted by CapGemini in their South San Francisco offices. The panel was composed of industry experts with up to 20 years experience in regulatory affairs: Dr. Urte Gayko (Nodality, VP of Regulatory and Clinical Affairs), Dr. Christine Conroy (Affymax, VP of Regulatory Affairs and GCP Compliance) and Dr. Sandra Nino-Siddens (Geron Corporation) Executive Director,Regulatory Affairs). The panel was moderated by Dr. Anne-Marie Duliege (Affymax, Chief Medical Officer).

Silicon Valley BioTalks: How CDISC standards streamline clinical trials  

How CDISC standards streamline clinical trials

March 7th, 2012 - Read the extracts

On March 7th 2012, Clinovo hosted the third Silicon Valley Biotalks, hosted by SNR Denton in their Palo Alto offices. The event welcomed over 60 professionals from the biotechnology and pharmaceuticals industry. The panel was composed of top-tier CDISC experts: John Brega (PharmaStat) CDISC Implementation and eCTD Submissions, Carey Smoak (Roche Molecular) Senior Manager, SAS Programming and CDISC Device Team Leader, Dave Borbas (Jazz Pharmaceuticals) Senior Director, Data Management, and Ale Gicqueau, President & CEO at Clinovo.

Silicon Valley BioTalks return on event  

Run Efficient Clinical Trials With Open Source Technologies

June 29th, 2011 - Read the extracts

On June 29th 2011, 50 professionals from the biotechnology and pharmaceuticals industry attended the event. The panel was composed of Victor Chen, Director of Clinical Affairs at Intuitive Surgical, Eric Morrie, Clinical Programming Manager at Abbott Vascular and Ale Gicqueau, President & CEO at Clinovo. Read the extracts.

Silicon Valley BioTalks the quarterly event for clinical trial professionals  

Implementing Adaptive Clinical Trials

Novembe​r 2nd, 2011 - Read the extracts.

Panelists from leading pharmaceutical and biotechnology companies will address key benefits and limitations of adaptive clinical trials. The panel includes representatives from Theravance, Xenoport, MAP Pharmaceuticals, ARA, Arincal and Clinovo. Leveraging years of experience and expertise, they will explain how adaptive designs help streamline the clinical trial process. 

 

Sophie McCallum, marketing & HR manager at Clinovo

 

Contact information

Sophie McCallum
Director of Operations
408-773-6258
sophie.mccallum@clinovo.com